Dario Health, a maker of devices and software to track diabetes care and other chronic conditions., has gone public, raising a measly $7.2 million. I can't for the life of me understand how desperate you must be to go through the hassle of being public for such a small amount of capital.
Children's behavioral health company Mightier gets stronger with an infusion of $6.6 million in capital. Hope I won't be writing soon about how the Mightier have fallen.
Health at Scale gets a weighty $16 million round of financing, all coming from the Optum division of UnitedHealth, to fund its artificial intelligence software to match patients with treatments.
Solera Health won't be going it alone, raising $42 million in new capital to support matching patients with providers and treatment plans for chronic diseases.
Jawbone Health talks a good game, and apparently needs lots of capital to do it, as the firm gets $65 million to do some poorly-articulated thing about taking lots of data and helping people avoid preventable diseases. When will investors learn.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.